ZYBULIN
Dead / Cancelled — Cancelled — Section 8 (as of 09 Nov 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85329641
- Registration number
- 4123117
- Mark type
- Stylized text
- Filed
- 25 May 2011
- Published for opposition
- 18 Oct 2011
- Registered
- 03 Apr 2012
- Attorney of record
- Michael J. Bevilacqua
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer
Owner
- ZIOPHARM Oncology, Inc., Boston, MA, US
- ZIOPHARM Oncology, Inc., Boston, MA, US
- ZIOPHARM Oncology, Inc., Boston, MA, US
Prosecution history
- 09 Nov 2018 — CANCELLED SEC. 8 (6-YR)
- 03 Apr 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Apr 2012 — REGISTERED-PRINCIPAL REGISTER
- 29 Feb 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Feb 2012 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 25 Feb 2012 — ASSIGNED TO LIE
- 09 Feb 2012 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Feb 2012 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jan 2012 — USE AMENDMENT FILED
- 07 Feb 2012 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Jan 2012 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2011 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Oct 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2011 — PUBLISHED FOR OPPOSITION
- 12 Sept 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER